TipRanks
Prime Medicine, Inc. (PRME)
NASDAQ:PRME
US Market
PRME
Prime Medicine, Inc.
RESEARCH TOOLSreports
Want to see PRME full AI Analyst Report?

Prime Medicine, Inc. (PRME) Stock News & Sentiment

935 Followers
PRME Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
PRME Earnings this Week: How Will it Perform?
4d ago
PRME
Prime Medicine Maintained at Buy with Unchanged $6 Price Target on Emerging Program Clarity and 2027 Catalysts
Premium
Ratings
Prime Medicine Maintained at Buy with Unchanged $6 Price Target on Emerging Program Clarity and 2027 Catalysts
3M ago
PRME
Prime Medicine Advances First-in-Human Prime Editing Trial in Wilson Disease
Premium
Company Announcements
Prime Medicine Advances First-in-Human Prime Editing Trial in Wilson Disease
3M ago
PRME
Prime Medicine: Buy Rating Reiterated with Unchanged $5 Price Target on Emerging Clinical Catalysts in Wilson’s Disease
Premium
Ratings
Prime Medicine: Buy Rating Reiterated with Unchanged $5 Price Target on Emerging Clinical Catalysts in Wilson’s Disease
3M ago
PRME
Prime Medicine Buy Rating Reiterated as Pipeline Advances; $6 Price Target Maintained
Premium
Ratings
Prime Medicine Buy Rating Reiterated as Pipeline Advances; $6 Price Target Maintained
3M ago
PRME
Prime Medicine resolves arbitration, clarifying PM647 development rights
Premium
Company Announcements
Prime Medicine resolves arbitration, clarifying PM647 development rights
4M ago
8K
PRME
CYTK, PRME, DOCS, WBD, LQDA Trending With Analysts
Premium
Weekend Updates
CYTK, PRME, DOCS, WBD, LQDA Trending With Analysts
4M ago
WBD
CYTK
More PRME News >

PRME News on the Web

Chardan Capital Sticks to Their Buy Rating for Prime Medicine, Inc. (PRME)
TipRanks News
Bullish
Prime Medicine, Inc. at Morgan Stanley Global Healthcare Conference Transcript
GuruFocus News
Neutral
Prime Medicine transferred with Buy rating at Chardan
TipRanks News
Bullish
Chardan Capital Reaffirms Their Buy Rating on Prime Medicine, Inc. (PRME)
TipRanks News
Bullish
Prime Medicine initiated with an Outperform at BMO Capital
TipRanks News
Bullish
Prime Medicine Advances First-in-Human Prime Editing Trial in Wilson Disease
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: Aligos Therapeutics (ALGS), aTyr Pharma (ATYR) and Prime Medicine, Inc. (PRME)
TipRanks News
Bullish
Cathie Wood Dumps AMD, Doubles Down on Meta Stock
GuruFocus News
Neutral

News Score - Last 7 Days

Neutral
PRME
Sector Average
Media Buzz
This Week2 articles
Weekly Average1.25 articles
News Sentiment
This Week100%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is PRME’s Media Buzz Sentiment?
2 articles about PRME were published this week. In an average week, 1.25 articles are published.
    What is PRME’s weekly average amount of articles?
    In an average week, 1.25 articles about PRME are published.
      What is PRME’s News Sentiment?
      100% of articles about PRME were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        GKOSGlaukos
        CNCCentene
        ASNDAscendis Pharma
        GILDGilead Sciences
        MRKMerck & Company
        Showing the stocks with the most bullish news sentiment over the past week